Search

Search Results
Results 1 - 3 of 3 for Cyclosert polymers
  • Supplier Profile
    Insert Therapeutics is focused on designing, developing and commercializing delivery-enhanced therapeutics using our patented class of polymeric delivery systems, which we have called our " Cyclosert™...
  • Article - 23 Apr 2004
    Arrowhead Research Corporation, an emerging company in the field of nanotechnology, has agreed to take a majority position in Insert Therapeutics, a company focused on designing, developing and...
  • News - 25 Sep 2007
    Insert Therapeutics, Inc., a majority-owned subsidiary of Arrowhead Research Corporation, announced today the issuance of a patent covering its lead oncology product, IT-101. IT 101 is a conjugate of...